Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
Read MoreAugust 22, 2016
Editas Medicine Names Charles Albright as Chief Scientific Officer
Read More